IP Library Granted Patent US 11,819,650
Granted Patent B2
US 11,819,650 · App. 17/125,992 · Granted Nov 21, 2023

Method of manufacturing multi-analyte microsensor with microneedles

Inventors: Ashwin Pushpala (San Francisco, CA); Alan Szmodis (San Francisco, CA); Matthew Chapman (San Francisco, CA); Weldon Hall (San Francisco, CA); Scott Miller (San Francisco, CA); Hooman Hafezi (San Francisco, CA)
Assignee: One Drop Biosensor Technologies, LLC
A61M37/0015A61B5/1495A61B5/14503A61B5/14514A61B5/14532A61B5/14546A61B5/14865A61B5/150022A61B5/150282A61B5/150427A61B5/150969A61B5/150984A61B5/4839A61B5/685C12Q1/006G01N27/3271A61B2562/028A61B2562/12A61B2562/125A61M25/00A61M2037/0023A61M2037/0046A61M2037/0053Y10T29/49117
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,819,650
App. No.
17/125,992
Granted
Nov 21, 2023
Kind
B2
Abstract

A microsensor and method of manufacture for a microsensor, comprising an array of filaments, wherein each filament of the array of filaments comprises a substrate and a conductive layer coupled to the substrate and configured to facilitate analyte detection. Each filament of the array of filaments can further comprise an insulating layer configured to isolate regions defined by the conductive layer for analyte detection, a sensing layer coupled to the conductive layer, configured to enable transduction of an ionic concentration to an electronic voltage, and a selective coating coupled to the sensing layer, configured to facilitate detection of specific target analytes/ions. The microsensor facilitates detection of at least one analyte present in a body fluid of a user interfacing with the microsensor.

Claims (49)

1. A wearable monitoring device for monitoring of a user, comprising:

an electrochemical microsensor configured to detect at least one physiological parameter and at least one analyte parameter, the electrochemical microsensor including at least one analyte sensing microneedle array configured to access interstitial fluid in the user and configured for in vivo detection of a plurality of analytes in the interstitial fluid, wherein the at least one analyte sensing microneedle array includes microneedles each having a detection end portion and a non-detection electrically insulated needle body extending from the detection end portion, wherein the electrochemical microsensor is configured to generate one or more signals associated with detection of at least one of the plurality of analytes isolated to the detection end portions positioned in the user's skin; and

an electronics module in communication with the electrochemical microsensor and configured to:

receive the one or more signals from the microneedles that are positioned in the user's skin,

analyze the received one or more signals to determine analyte information for the user, and

wherein the wearable monitoring device is configured to output event information based on both the at least one physiological parameter and the at least one analyte parameter.

2. The wearable monitoring device of claim 1 , wherein the detection end portions include detection tips configured generate the one or more signals, and wherein the non-detection electrically insulated needle bodies are configured to transmit the one or more signals to the electronics module.

3. A wearable monitoring device for monitoring of a user, comprising:

an electrochemical microsensor including at least one analyte sensing microneedle array configured to access interstitial fluid in the user and configured for in vivo detection of a plurality of analytes in the interstitial fluid, wherein the at least one analyte sensing microneedle array includes microneedles each having a detection end portion and a non-detection electrically insulated needle body extending from the detection end portion, wherein the electrochemical microsensor is configured to generate one or more signals associated with detection of at least one of the plurality of analytes isolated to the detection end portions positioned in the user's skin; and

an electronics module in communication with the electrochemical microsensor and configured to:

receive the one or more signals from the microneedles that are positioned in the user's skin, and

analyze the received one or more signals to determine analyte information for the user, and

wherein the wearable monitoring device is configured to:

detect at least one physiological parameter and at least one analyte parameter, and

automatically identify a health problem or a health-related event based on both the at least one physiological parameter and the at least one analyte parameter.

4. The wearable monitoring device of claim 1 , wherein the electronics module is programmed to determine analyte information that includes at least one of:

a concentration of the plurality of analytes, or

a level of the plurality of analytes.

5. The wearable monitoring device of claim 1 , wherein the analyte information includes at least one of:

presence of one or more biomarkers in the interstitial fluid, or

drug concentration in the interstitial fluid.

6. The wearable monitoring device of claim 1 , wherein the at least one analyte sensing microneedle array includes multi-analyte microneedles configured to independently detect analytes.

7. The wearable monitoring device of claim 1 , wherein the electrochemical microsensor is configurable for continuous or intermittent monitoring based on the plurality of analytes to be detected.

8. The wearable monitoring device of claim 1 , wherein

the electrochemical microsensor is configured to output first signals associated with detection of a first analyte of the plurality of analytes and second signals associated with detection of a second analyte of the plurality of analytes, and

the electronics module is configured to determine:

a presence or concentration of the first analyte based on the first signals, and

a presence or concentration of the second analyte based on the second signals.

9. The wearable monitoring device of claim 1 , wherein the at least one analyte sensing microneedle array includes a first needle array configured to detect a first analyte and a second needle array configured to detect a second analyte.

10. A wearable monitoring device, comprising:

a microsensor configured to detect at least one physiological parameter and at least one analyte parameter, the microsensor including microneedles configured to access interstitial fluid in a user and detect in vivo at least one analyte in the interstitial fluid, wherein one or more of the microneedles have a detection end portion and a non-detection electrically insulated needle body extending from the detection end portion, wherein the microsensor is configured to generate one or more signals associated with detection by the detection end portion of the at least one analyte; and

an electronics module in communication with the microsensor and configured to:

receive the one or more signals from the microsensor,

analyze the received one or more signals to determine analyte information for the user, and

automatically identify a health problem or a health-related event based on both the at least one physiological parameter and the at least one analyte parameter.

11. The wearable monitoring device of claim 10 , wherein:

the microsensor is configured to output first signals associated with detection of a first analyte, second signals associated with detection of a second analyte, and third signals associated with detection of the at least one physiological parameter, and

the electronics module is configured to determine:

(a) a presence or concentration of the first analyte based on the first signals,

(b) a presence or concentration of the second analyte based on the second signals, and

(c) a health problem or a health-related event of the user based on (a) and (b) in conjunction with the at least one physiological parameter.

12. The wearable monitoring device of claim 10 , wherein the microsensor includes:

a first analyte sensing microneedle array, and

a second analyte sensing microneedle array.

13. A wearable monitoring device, comprising:

a microsensor including microneedles configured to access interstitial fluid in a user and detect in vivo at least one analyte in the interstitial fluid, wherein one or more of the microneedles have a detection end portion and a non-detection electrically insulated needle body extending from the detection end portion, wherein the microsensor is configured to generate one or more signals associated with detection by the detection end portion of the at least one analyte, wherein the one or more of the microneedles are configured to detect the at least one analytes within the skin; and

an electronics module in communication with the microsensor and configured to:

receive the one or more signals from the microsensor, and

analyze the received one or more signals to determine analyte information for the user.

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 1, 2024
From: ONE DROP BIOSENSOR TECHNOLOGIES, LLC
To: ONE HEALTH BIOSENSING INC.
Reel/Frame 066970/0874 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 2, 2021
From: PUSHPALA, ASHWIN; SZMODIS, ALAN; CHAPMAN, MATTHEW; HALL, WELDON; MILLER, SCOTT; HAFEZI, HOOMAN
To: SANO INTELLIGENCE, INC.
Reel/Frame 055119/0632 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 2, 2021
From: SANO INTELLIGENCE, INC.
To: ONE DROP BIOSENSOR TECHNOLOGIES, LLC
Reel/Frame 055119/0673 →
Continuity (7)
Continuation 16886742 · May 28, 2020
Continuation 16722977 · Dec 20, 2019
Continuation 14876692 · Oct 6, 2015
Continuation 14211404 · Mar 14, 2014
Provisional Application 61905583 · Nov 18, 2013
Provisional Application 61781754 · Mar 14, 2013
Related Publication 20210100504A1 · Apr 8, 2021
Cited By (8)
US 12,279,888 US 12,285,271 US 12,336,816 US 12,369,830 US 12,453,516 US 12,599,337 US 12,605,100 US 12,629,060